Pharmaceutical

Stalica raises $17.5m to advance neurology programmes

The Switzerland based company plans to use the Series B money to fund clinical trials for its three pipeline candidates.

Jan 17, 2024 - 18:00
Stalica raises $17.5m to advance neurology programmes
The Switzerland based company plans to use the Series B money to fund clinical trials for its three pipeline candidates.
Read the original article

Tags:

Previous Article

EU access to oncology medicines lags behind in the Netherlands

Next Article

KBI Biopharma and Argonaut form drug manufacturing alliance

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Tempus AI expands oncology collaboration with Takeda

Tempus AI expands oncology collaboration with Takeda

Sep 28, 2024

FDA grants rare paediatric drug status for IPS HEART’s stem cell drugs

FDA grants rare paediatric drug status for IPS HEART’s ...

Apr 14, 2023

FDA RMAT status for Affimed and Artiva’s lymphoma combo therapy

FDA RMAT status for Affimed and Artiva’s lymphoma combo...

Dec 9, 2024